Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| PBRC28016 | Other Identifier | Ajinomoto Co., Inc |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ajinomoto USA, INC. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A 4 week intake of drug to find a natural substance that may modify energy balance and may enhance health in combination with lifestyle changes with possible decrease in body weight.
This study is a double-blind, placebo-controlled, single center, randomized, parallel arm clinical trial to test the impact of Dihydrocapsiate (placebo, 3 and 9 mg/d) ingested for 4 weeks on resting metabolic rate and fat oxidation measured by indirect calorimetry.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sugar pill (Placebo o mg/d) | Placebo Comparator | 0 mg/d sugar pill |
|
| Dihydrocapsiate | Active Comparator | Drug 3 mg/d or 9 mg/d including Placebo |
|
| 3 mg/d or 9 mg/d Dihydrocapsiate | Active Comparator | Drug including Placebo |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dihydrocapsiate | Other | Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo |
|
| Measure | Description | Time Frame |
|---|---|---|
| The consumption of dihydrocapsiate will significantly increase resting energy expenditure and fat oxidation | 4 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eric Ravussin, PhD | Pennington Biomedical Research Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70809 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 19671203 | Result | Galgani JE, Ryan DH, Ravussin E. Effect of capsinoids on energy metabolism in human subjects. Br J Nutr. 2010 Jan;103(1):38-42. doi: 10.1017/S0007114509991358. Epub 2009 Aug 12. | |
| 20826626 | Derived | Galgani JE, Ravussin E. Effect of dihydrocapsiate on resting metabolic rate in humans. Am J Clin Nutr. 2010 Nov;92(5):1089-93. doi: 10.3945/ajcn.2010.30036. Epub 2010 Sep 8. |
| Label | URL |
|---|---|
| Effect of capsinoids on energy metabolism in human subjects | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D001835 | Body Weight |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C470213 | capsiate |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dihydrocapsiate | Other | Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo |
|
|
| Dihydrocapsiate | Other | Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo |
|
|
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |